col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: Federal Medical Biological Agency
  original article Journal Date Title Authors All Authors
1 [GO] Medicine of Extreme Situations 2021―Sep―30 Experimental and clinical evaluation of mefloquine effectiveness against the infection caused by SARS-CoV-2 KN Filin, VD Gladkikh, VN Bykov
2 [GO] Medicine of Extreme Situations 2021―Sep―17 Respiratory muscle strength in patients after COVID-19 OI Savushkina, MM Malashenko, AV Cherniak, EV Krjukov, EA Sinitsyn, KA Zykov
3 [GO] Medicine of Extreme Situations 2021―Jun―30 Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 infection YuV Lobzin, AN Uskov, NV Skripchenko, AA Vilnits, MK Bekhtereva, IV Babachenko
4 [GO] Medicine of Extreme Situations 2021―Jun―30 Method for quantitative assessment of protective immunity against SARS-CoV-2, its duration and antibody dynamics AM Karmishin, NYu Nosov, VB Postupailo, BA Zhigarlovskiy, AA Kruglov, AN Petukhov
5 [GO] Medicine of Extreme Situations 2021―Jun―19 Evaluation of efficacy of the amino acid-peptide complex administered intragastrically to golden hamsters experimentally infected with SARS-CoV-2 DS Laptev, GA Protasova, SG Petunov, AS Radilov, SV Chepur, AS Gogolevskiy, et al. (+3)
6 [GO] Medicine of Extreme Situations 2021―Feb―16 Epidemiological characteristics of community-acquired pneumonia during the COVID-19 epidemic in the Russian Federation BA Zhigarlovskiy, NF Nikityuk, VB Postupailo, AA Goryaev, EV Belov, NYu Nosov, et al. (+3)
7 [GO] Medicine of Extreme Situations 2020―Dec―20 Dynamics and logic of COVID-19 containment measures YuV Raskina, AA Novkunskaya, AA Barchuk
8 [GO] Medicine of Extreme Situations 2020―Dec―20 Endothelial dysfunction in COVID-19 patients and clinical application of laser therapy AV Kochetkov, NYu Ponomareva, NG Kadnikova, VG Mitkovskij, EN Yampolskaya, VV Lazarev
9 [GO] Medicine of Extreme Situations 2020―Dec―14 Effectiveness of immobilized probiotics for complex therapy of novel coronavirus infection COVID-19 in hospital settings NG Bomshteyn, YuV Bolotov, IA Kim, DV Trukhin
10 [GO] Medicine of Extreme Situations 2020―Dec―13 Using experimental ex vivo models to develop COVID-19 pathogenetic therapy and complications prevention agents DS Laptev, SG Petunov, OV Nechaykina, DV Bobkov, AS Radilov
11 [GO] Medicine of Extreme Situations 2020―Dec―03 Surgical care arrangement at the general hospital during the COVID-19 pandemic YaA Nakatis, VA Ratnikov, VA Kashchenko, AV Lodygin, AI Mitsinskaya, MA Mitsinskii, AD Akhmetov
12 [GO] Medicine of Extreme Situations 2020―Dec―02 Sars-CoV-2 in the context of coronaviruses and animal models of COVID-19 AA Korenkova, VV Bahmetjev, KS Gorbunov
13 [GO] Medicine of Extreme Situations 2020―Nov―30 COVID-19 in ophthalmic practice KhP Takhchidi, NKh Takhchidi, MKh Movsesian
14 [GO] Medicine of Extreme Situations 2020―Aug―19 Development of the kit for diagnostics of COVID-19 by real time RT-PCR AK Shuryaeva, TV Malova, EE Davydova, YuA Savochkina, EV Bogoslovskaya, RR Mintaev, et al. (+6)
15 [GO] Medicine of Extreme Situations 2020―Aug―19 Inobvious pathogenetic links of mechanisms effects on the human organism of the SARS-CoV-2 virus IB Ushakov, AN Parfyonov, RA Bondarenko, VN Komarevtsev
16 [GO] Medicine of Extreme Situations 2020―Aug―18 Hyperbaric oxygen therapy in treatment of COVID-19 complicated cases: first application experience review ED Mozgovoy, YuD Udalov, MV Ochkolias
17 [GO] Medicine of Extreme Situations 2020―Aug―18 Study of the effectiveness of methylprednisolone at different stages of inpatient care for patients with pneumonia caused by a new COVID-19 coronavirus infection EE Arinina, RT Tairova, AB Berdalin, SS Gujev, NA Glotova, YuV Rubleva, et al. (+4)
18 [GO] Medicine of Extreme Situations 2020―Aug―17 Medical evacuation of patients COVID-19 NN Baranova, AV Akin'shin, SF Goncharov, MA Meshkov, KM Zelentsov, VP Pys'mennij
19 [GO] Medicine of Extreme Situations 2020―Aug―17 Countermeasures against the introduction and spread of coronavirus infection COVID-19 in medical organizations VV Nikiforov, TG Suranova, VN Komarevtsev, SYu Khlutkov, VI Skvortsova
20 [GO] Medicine of Extreme Situations 2020―Aug―10 Experimental evaluation of the activity of the product meflochine against coronavirus SАRS-CoV-2 KN Filin, IA Berzin, VN Bykov, VD Gladkikh, SYa Loginova, SV Savenko, VN Schukina
21 [GO] Medicine of Extreme Situations 2020―Aug―08 Actual problems of psychological support of healthcare workers in infectious hospitals for patients with COVID-19 in the territory of the Krasnoyarsk region MS Sevostyanova, NV Selezneva, PA Chernomurova, ZS Kharchenko, KV Glushkova, AO Fetisov, et al. (+2)
22 [GO] Medicine of Extreme Situations 2020―Jul―30 Genetic determinants of the response to coronavirus infection COVID-19 SV Poyarkov, VV Makarov, SA Kraevoy, SM Yudin
23 [GO] Medicine of Extreme Situations 2020―Jul―30 Effect of physical activity level on the course of pneumonia caused by COVID-19 AS Samoylov, YuD Udalov, SE Nazaryan, AV Naikina
24 [GO] Medicine of Extreme Situations 2020―Jul―29 Justification of the possible directions of pathogenetic therapy of a new coronavirus infection YuV Lobzin, MB Ivanov, EB Shustov, VL Rejnyuk, AV Fomichev, AE Sosyukin, BS Litvincev
25 [GO] Medicine of Extreme Situations 2020―Jul―29 Clinical and epidemiological features of the new coronavirus infection COVID 19 in the central black region IE Esaulenko, VI Popov, TN Petrova, AYu Goncharov


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.010 sec